BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32468470)

  • 1. Biomarkers as a Different Approach in Prevention and Treatment of Drug Addiction (Preliminary Study).
    Gonidi M; Tselenti A; Plerou A
    Adv Exp Med Biol; 2020; 1195():151-154. PubMed ID: 32468470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Content, Multi-Parameter Analyses in Buccal Cells to Identify Alzheimer's Disease.
    François M; Fenech MF; Thomas P; Hor M; Rembach A; Martins RN; Rainey-Smith SR; Masters CL; Ames D; Rowe CC; Macaulay SL; Hill AF; Leifert WR; The Australian Imaging Biomarkers And Lifestyle Study Research Group
    Curr Alzheimer Res; 2016; 13(7):787-99. PubMed ID: 26975368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyostomatitis vegetans: cellular immune profile and expression of IL-6, IL-8 and TNF-alpha.
    Ficarra G; Baroni G; Massi D
    Head Neck Pathol; 2010 Mar; 4(1):1-9. PubMed ID: 20237982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central and Peripheral Biomarkers of Stress Response for Addiction Risk and Relapse Vulnerability.
    Milivojevic V; Sinha R
    Trends Mol Med; 2018 Feb; 24(2):173-186. PubMed ID: 29396148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focusing on the Opioid System for Addiction Biomarker Discovery.
    Belzeaux R; Lalanne L; Kieffer BL; Lutz PE
    Trends Mol Med; 2018 Feb; 24(2):206-220. PubMed ID: 29396147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of buccal mucosal transudate collected with a buccal swab and urine levels of cocaine.
    Leonard J; Doot M; Martin C; Airth-Kindree W
    J Addict Dis; 1994; 13(1):27-33. PubMed ID: 8018738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered cytological parameters in buccal cells from individuals with mild cognitive impairment and Alzheimer's disease.
    François M; Leifert W; Hecker J; Faunt J; Martins R; Thomas P; Fenech M
    Cytometry A; 2014 Aug; 85(8):698-708. PubMed ID: 24616437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical Diagnosis in Substance and Non-substance Addiction.
    Shen W; Liu H; Xie X; Liu H; Zhou W
    Adv Exp Med Biol; 2017; 1010():169-202. PubMed ID: 29098673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct inflammatory profiles in HIV-infected individuals under antiretroviral therapy using cannabis, cocaine or cannabis plus cocaine.
    Castro FOF; Silva JM; Dorneles GP; Barros JBS; Ribeiro CB; Noronha I; Barbosa GR; Souza LCS; Guilarde AO; Pereira AJCS; Guimarães RF; Oliveira TF; Oliveira SEF; Peres A; Romão PRT; Pfrimer IAH; Fonseca SGD
    AIDS; 2019 Oct; 33(12):1831-1842. PubMed ID: 31490211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buccal micronucleus cytome biomarkers in Algerian couples with idiopathic infertility.
    Laanani I; Boutelis S; Bennoune O; Belaaloui G
    Mutat Res Genet Toxicol Environ Mutagen; 2018 Nov; 835():32-35. PubMed ID: 30249480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk.
    Leifert WR; Nguyen T; Rembach A; Martins R; Rainey-Smith S; Masters CL; Ames D; Rowe CC; Macaulay SL; François M; Fenech MF;
    J Alzheimers Dis; 2015; 48(2):443-52. PubMed ID: 26402008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Metabolomics to Investigate Biomarkers of Drug Addiction.
    Ghanbari R; Sumner S
    Trends Mol Med; 2018 Feb; 24(2):197-205. PubMed ID: 29397321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of DNA Methylation in Drug Addiction: Implications for Diagnostic and Therapeutics.
    Lax E; Szyf M
    Prog Mol Biol Transl Sci; 2018; 157():93-104. PubMed ID: 29933958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buccal Mucosa Biomarkers in Alzheimer's Disease.
    Avramouli A; Vlamos P
    Adv Exp Med Biol; 2020; 1195():49-56. PubMed ID: 32468458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in substance use disorders.
    Volkow ND; Koob G; Baler R
    ACS Chem Neurosci; 2015 Apr; 6(4):522-5. PubMed ID: 25734247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining Substance Use Disorders: The Need for Peripheral Biomarkers.
    Bough KJ; Pollock JD
    Trends Mol Med; 2018 Feb; 24(2):109-120. PubMed ID: 29396146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders.
    García-Marchena N; Barrera M; Mestre-Pintó JI; Araos P; Serrano A; Pérez-Mañá C; Papaseit E; Fonseca F; Ruiz JJ; Rodríguez de Fonseca F; Farré M; Pavón FJ; Torrens M
    PLoS One; 2019; 14(3):e0213791. PubMed ID: 30870525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prospects of buccal epithelium application for noninvasive diagnosis of coronary heart disease in people of different age.].
    Bunin VA; Karpasova EA; Kozhevnikova EO; Linkova NS; Kozlov KL; Paltseva EM
    Adv Gerontol; 2018; 31(6):943-947. PubMed ID: 30877825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the physician in addiction prevention and treatment.
    Miller NS; Sheppard LM
    Psychiatr Clin North Am; 1999 Jun; 22(2):489-505. PubMed ID: 10385946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Epigenetics in Addiction: Clinical Overview and Recent Updates.
    Beayno A; El Hayek S; Noufi P; Tarabay Y; Shamseddeen W
    Methods Mol Biol; 2019; 2011():609-631. PubMed ID: 31273724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.